About
Cancer therapies
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalAntibodySouthwestern U.S.
Clinical Trials (13)
View allTotal Trials
13
As Lead Sponsor
7
As Collaborator
6
Total Enrollment
504
By Phase
NA: 4PHASE1: 6PHASE2: 3
By Status
UNKNOWN: 6COMPLETED: 5RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline13 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05728918Lead Sponsor
Effectiveness of Antrodia Cinnamomea Mycelia on Improving Immune Response in Subhealth People
NACompleted
25 participants
Started: Mar 1, 2023 · Completed: May 30, 2024
NCT05738655Lead Sponsor
Effectiveness of Pumpkin Seed Extract on Improving Blood Sugar Level in Subhealth Subjects
NARecruiting
60 participants
Started: Mar 1, 2023 · Completed: Oct 31, 2024
NCT05542160Lead Sponsor
Effectiveness of IRK-19® on Body Weight Control
NACompleted
50 participants
Started: Oct 1, 2022 · Completed: Jun 30, 2024
NCT05309161Lead Sponsor
Efficacy Testing of Crassocephalum Rabens Extract Capsules
NACompleted
40 participants
Started: Mar 14, 2022 · Completed: Jun 30, 2022
NCT03208556Collaborator
Safety and Efficacy of iPD1 CD19 eCAR T Cells in Relapsed or Refractory B-cell Lymphoma
PHASE1Unknown
20 participants
Started: Jun 21, 2017 · Completed: Jun 1, 2020
Locations (1)
Headquarters
Oklahoma City, OK, United States
Map
Loading map...